Introduction of SLC44A1
Solute carrier family 44 member 1 (SLC44A1), also known as CDw92 or CTL1, is a transmembrane protein that in human is encoded by SLC44A1 gene. SLC44A1 belongs to the choline transporter-like (CTL) family and is identified as a Naþ-independent, intermediate-affinity transporter of choline. SLC44A1 is broadly expressed in various cells of the hematopoietic system. It is also found in the human central nervous system (CNS), including neuronal, glial and endothelial cells.
Basic Information of SLC44A1 | |
Protein Name | Choline transporter-like protein 1 |
Gene Name | SLC44A1 |
Aliases | CDw92, Solute carrier family 44 member 1, CD antigen: CD92 |
Organism | Homo sapiens (Human) |
UniProt ID | Q8WWI5 |
Transmembrane Times | 9 |
Length (aa) | 657 |
Sequence | MGCCSSASSAAQSSKREWKPLEDRSCTDIPWLLLFILFCIGMGFICGFSIATGAAARLVSGYDSYGNICGQKNTKLEAIPNSGMDHTQRKYVFFLDPCNLDLINRKIKSVALCVAACPRQELKTLSDVQKFAEINGSALCSYNLKPSEYTTSPKSSVLCPKLPVPASAPIPFFHRCAPVNISCYAKFAEALITFVSDNSVLHRLISGVMTSKEIILGLCLLSLVLSMILMVIIRYISRVLVWILTILVILGSLGGTGVLWWLYAKQRRSPKETVTPEQLQIAEDNLRALLIYAISATVFTVILFLIMLVMRKRVALTIALFHVAGKVFIHLPLLVFQPFWTFFALVLFWVYWIMTLLFLGTTGSPVQNEQGFVEFKISGPLQYMWWYHVVGLIWISEFILACQQMTVAGAVVTYYFTRDKRNLPFTPILASVNRLIRYHLGTVAKGSFIITLVKIPRMILMYIHSQLKGKENACARCVLKSCICCLWCLEKCLNYLNQNAYTATAINSTNFCTSAKDAFVILVENALRVATINTVGDFMLFLGKVLIVCSTGLAGIMLLNYQQDYTVWVLPLIIVCLFAFLVAHCFLSIYEMVVDVLFLCFAIDTKYNDGSPGREFYMDKVLMEFVENSRKAMKEAGKGGVADSRELKPMASGASSA |
Function of SLC44A1 Membrane Protein
SLC44A1 has been considered as a key mediator of choline transport across both the plasma membrane and the mitochondrial membrane, and it might mediate choline transport into and out of mitochondria to ensure an immediate sink of cellular choline generated from PC and sphingomyelin metabolism. SLC44A1 may also play a role in membrane synthesis and myelin production. The SLC44A1 choline transport system utilizes a directed H+ gradient as a driving force, and its transport function is in cooperation with Naþ/Hþ exchangers. In addition, it has been indicated that malfunction of SLC44A1 could have significant implications in nervous system development and repair following injury, as well as in neurodegenerative diseases. A study focused on the small cell lung carcinoma shows that the functional inhibition of SLC44A1 could promote apoptotic cell death. And thus, the SLC44A1-mediated choline transport system provides a potential novel target for therapeutic intervention. Furthermore, SLC44A1 may also play a role in the transport of various cationic drugs as a drug transporter in the blood-brain barrier (BBB).
Fig.1 Choline transporter CTL1 locates at the trans-Golgi network (TGN), a post-Golgi compartment acting as a central hub in the cell where endosomal plasma membrane recycling takes place as well as secretory sorting to plasma membrane and trafficking to late endosomes. (Boutté, 2018)
Application of SLC44A1 Membrane Protein in Literature
The results of this study show that extracellular choline is mainly transported via CTL1 and the functional inhibition of CTL1 by cationic drugs could promote apoptotic cell death.
This study identifies CTL1 as a putative complexing partner with NECL4, by mass spectrometry and western blotting techniques.
Authors of this study reveal that the phospholipids, sphingolipids, and other membrane lipids are significantly altered in the ctl1 mutant, which links the CTL1 function to lipid homeostasis.
Authors of this article demonstrate that CTL1 plays a role in regulating vesicle trafficking and therefore is required for the trafficking of proteins essential for ion transport and PD development.
Authors of this article investigate the molecular and functional characterization of choline transporter in human brain microvascular endothelial cells (hBMECs), and they suggest that choline is predominantly transported by an intermediate-affinity choline transport system, CTL1 and CTL2, in hBMECs.
SLC44A1 Preparation Options
To prepare the soluble and functional target protein of your interest, we now provide a comprehensive solution for SLC44A1 preparation with fast turnaround times. Our Magic™ membrane protein production platform can significantly accelerate your membrane protein studies. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC44A1 antibody development services.
As a world leader in the industry of membrane protein, Creative Biolabs is committed to offering expert high-quality contract research services, especially membrane protein preparation studies. Moreover, according to your special requirements, our experienced scientists are able to offer customized services. Please feel free to contact us for more details.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.